TTVR Early Feasibility Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 150 participants.

Also called NCT04433065

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
  • Medtronic Registry lists this organization as the lead sponsor
Registry
  • NCT NCT04433065
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT04433065. Allocation not applicable; no masking; primary purpose treatment. Start 2020-10-20 (actual); primary completion 2026-08-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
TTVR Early Feasibility Study
Condition
Tricuspid Regurgitation
Intervention (Device)
Intrepid™ TTVR System
Lead sponsor
Medtronic Cardiovascular (class: industry)

Record details

Record id
cardio:ct-nct04433065
Content hash
6e27101d22b7ebb8a4334f7da0b390018cf3042df12dce7d5acfbe61632ba49a